Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleThe State of the Art

The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective

Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
Journal of Nuclear Medicine June 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996
Sze Ting Lee
1Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia;
2Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia;
3Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia;
4School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise M. Emmett
5Department of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia;
6St. Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Pattison
7Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia;
8School of Medicine, University of Queensland, Brisbane, Queensland, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S. Hofman
9Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;
10Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;
11Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale L. Bailey
12Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa J. Latter
7Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia;
8School of Medicine, University of Queensland, Brisbane, Queensland, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roslyn J. Francis
13Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; and
14Medical School, University of Western Australia, Perth, Western Australia, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew M. Scott
1Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia;
2Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia;
3Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia;
4School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

In nuclear medicine, theranostics is a burgeoning development that is rapidly being implemented worldwide. There is an increasing need to provide a multidisciplinary framework to the practice of theranostics, ensuring that patients receive this treatment safely and are secure in the knowledge that their health-care practitioners are adequately trained. Nuclear medicine experts in Australia have taken the initiative of producing a set of theranostic guidelines relevant to Australian medical practice. These guidelines encompass specialist qualifications, patient care, radiopharmaceutical production, radiation safety, and dosimetry. We propose adaptation of these guidelines by other countries, and we promote standards of practice leading to optimal clinical outcomes for patients receiving theranostic treatments.

  • molecular imaging
  • general oncology
  • radionuclide therapy
  • guidelines
  • theranostics
  • training

Footnotes

  • Published online Apr. 7, 2021.

  • © 2022 by the Society of Nuclear Medicine and Molecular Imaging.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (6)
Journal of Nuclear Medicine
Vol. 63, Issue 6
June 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis, Andrew M. Scott
Journal of Nuclear Medicine Jun 2022, 63 (6) 819-822; DOI: 10.2967/jnumed.122.263996

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis, Andrew M. Scott
Journal of Nuclear Medicine Jun 2022, 63 (6) 819-822; DOI: 10.2967/jnumed.122.263996
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • SYNOPSIS OF AANMS POSITION STATEMENT
    • TRAINING AND ACCREDITATION
    • THERANOSTIC COMMITTEE
    • CONCLUSION
    • Disclosure
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Guideline for Clinicians Performing Clinical Studies with Fluorescence Imaging
  • Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development
Show more The State of The Art

Similar Articles

Keywords

  • Molecular Imaging
  • general oncology
  • Radionuclide Therapy
  • guidelines
  • theranostics
  • training
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire